SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Megan K. Herbert, Jorine M. Eeftens, Marjolein B. Aerts, Rianne A.J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek, CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls, Parkinsonism & Related Disorders, 2014, 20, 1, 112

    CrossRef

  2. 2
    Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi, Manuchair Ebadi, Biomarkers in Parkinson’s disease (recent update), Neurochemistry International, 2013, 63, 3, 201

    CrossRef

  3. 3
    Mona K. Beyer, Guido Alves, Kristy S. Hwang, Sona Babakchanian, Kolbjorn S. Bronnick, Yi-Yu Chou, Turi O. Dalaker, Martin W. Kurz, Jan P. Larsen, Johanne H. Somme, Paul M. Thompson, Ole-Bjørn Tysnes, Liana G. Apostolova, Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease, Movement Disorders, 2013, 28, 3
  4. 4
    Takahiko Tokuda, Aiming to develop biochemical biomarkers for Parkinson's disease and related disorders, Rinsho Shinkeigaku, 2012, 52, 11, 1332

    CrossRef

  5. 5
    Takashi Kasai, Takahiko Tokuda, Development of Diagnostic Biomarkers for Neurodegenerative Diseases, Nihon Naika Gakkai Zasshi, 2012, 101, 11, 3247

    CrossRef

  6. 6
    Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben A. Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C. Rodriguez-Oroz, David J. Burn, Roger A. Barker, Murat Emre, Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, Movement Disorders, 2012, 27, 3
  7. 7
    Aleksandar Ignjatović, Zorica Stević, Dragana Lavrnić, Aleksandra Nikolić-Kokić, Duško Blagojević, Mihajlo Spasić, Ivan Spasojević, Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients, Amyotrophic Lateral Sclerosis, 2012, 13, 4, 357

    CrossRef

  8. 8
    Kurt A. Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2, 75

    CrossRef

  9. 9
    Lama M. Chahine, Matthew B. Stern, Diagnostic markers for Parkinsonʼs disease, Current Opinion in Neurology, 2011, 24, 4, 309

    CrossRef

  10. 10
    Irene Litvan, Dag Aarsland, Charles H. Adler, Jennifer G. Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C. Rodriguez-Oroz, Alexander I. Tröster, Daniel Weintraub, MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI, Movement Disorders, 2011, 26, 10
  11. 11
    Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline Tanner, Tanya Simuni, Chris Coffey, Karl Kieburtz, Emily Flagg, Sohini Chowdhury, Werner Poewe, Brit Mollenhauer, Paracelsus-Elena Klinik, Todd Sherer, Mark Frasier, Claire Meunier, Alice Rudolph, Cindy Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Ying Zhang, Arthur Toga, Karen Crawford, Alison Ansbach, Pasquale De Blasio, Michele Piovella, John Trojanowski, Les Shaw, Andrew Singleton, Keith Hawkins, Jamie Eberling, Deborah Brooks, David Russell, Laura Leary, Stewart Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David Standaert, Stephanie Guthrie, Robert Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltan Mari, Melissa Gerstenhaber, David Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor Grachev, Kim Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor, The Parkinson Progression Marker Initiative (PPMI), Progress in Neurobiology, 2011, 95, 4, 629

    CrossRef

  12. 12
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  13. 13
    Edna Grünblatt, Sonja Zehetmayer, Christian P. Jacob, Thomas Müller, Wolfgang H. Jost, Peter Riederer, Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease, Journal of Neural Transmission, 2010, 117, 12, 1387

    CrossRef

  14. 14
    Raquel Duran, Francisco J. Barrero, Blas Morales, Juan D. Luna, Manuel Ramirez, Francisco Vives, Plasma α-synuclein in patients with Parkinson's disease with and without treatment, Movement Disorders, 2010, 25, 4
  15. 15
    Erik Su, Michael J. Bell, Stephen R. Wisniewski, P. David Adelson, Keri L. Janesko-Feldman, Rosanne Salonia, Robert S.B. Clark, Patrick M. Kochanek, Valerian E. Kagan, Hülya Bayır, α-Synuclein Levels Are Elevated in Cerebrospinal Fluid following Traumatic Brain Injury in Infants and Children: The Effect of Therapeutic Hypothermia, Developmental Neuroscience, 2010,

    CrossRef

  16. 16
    Kurt A. Jellinger, Parkinson's Disease,
  17. 17
    J. -P. Taylor, I. G. McKeith, The Lewy Body Dementia Spectrum (Alpha Synucleinopathies),